BD director granted 210 deferred stock rights

Becton Dickinson & Co director Robert Luther Huffines received 210 derivative rights to common stock under the BD Deferred Compensation Plan.

Rhea-AI Filing Summary

Becton Dickinson & Co director Robert Luther Huffines received 210 derivative rights to common stock under the BD Deferred Compensation Plan. The rights were granted at a reference price of $149.04 per right and increase his total deferred rights to 404.

Each right converts into one share of common stock, and the securities are distributed after his service as a director ends or on dates he previously specified. The total also reflects rights acquired through dividend reinvestment and adjustments related to combining the Biosciences and Diagnostic Solutions businesses with Waters Corp.

Insider Trade Summary

Grant/Award: 210 shares

Grant/Award 1 txn

Insider Huffines Robert Luther

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Rights to Common Stock Under BD Deferred Compensation Plan	210	$149.04	$31K

Holdings After Transaction: Rights to Common Stock Under BD Deferred Compensation Plan — 404 contracts (Direct)

Footnotes (4)

1. F1. The securities convert to common stock on a one-for-one basis.
2. F2. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
3. F3. Includes rights acquired through dividend investment since the last report filed by the reporting person.
4. F4. Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

Key Figures

Deferred rights granted: 210 rights Grant reference price: $149.04 per right Total deferred rights after grant: 404 rights +1 more

4 metrics

Deferred rights granted 210 rights Rights to Common Stock under BD Deferred Compensation Plan on May 8, 2026

Grant reference price $149.04 per right Price used for the 210 rights award

Total deferred rights after grant 404 rights Derivative securities following the reported transaction

Conversion ratio 1 right : 1 share Each right converts into one share of common stock

Key Terms

Deferred Compensation Plan, Rights to Common Stock, derivative securities, dividend investment, +1 more

5 terms

Deferred Compensation Plan financial

"Rights to Common Stock Under BD Deferred Compensation Plan"

A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.

Rights to Common Stock financial

"Rights to Common Stock Under BD Deferred Compensation Plan"

derivative securities financial

"the number of previously reported derivative securities held by the reporting person"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

dividend investment financial

"Includes rights acquired through dividend investment since the last report"

one-for-one basis financial

"The securities convert to common stock on a one-for-one basis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BDX director Robert Luther Huffines report?

Robert Luther Huffines reported receiving 210 rights to Becton Dickinson common stock under the BD Deferred Compensation Plan. These rights are a derivative-based award that adds to his existing balance and are structured to convert into common shares at a later distribution date.

How many deferred stock rights does the BDX director hold after this Form 4?

Following this transaction, Robert Luther Huffines holds 404 rights to Becton Dickinson common stock. This figure includes the 210 newly awarded rights, prior holdings, rights acquired through dividend investment, and adjustments tied to the Waters Corp business combination.

At what reference price were the new BDX deferred stock rights granted?

The 210 new rights were granted at a reference price of $149.04 per right. This price reflects the value used for the deferred compensation accounting and does not represent a cash purchase or sale in the open market by the reporting director.

When will the BDX deferred compensation rights be distributed to the director?

The deferred compensation rights are distributed after Robert Luther Huffines’ service as a director ends, or on specific dates he previously chose. This means the award is designed for long-term deferral, aligning payout timing with his board service and elected distribution schedule.

How do the reported rights relate to Becton Dickinson common stock?

Each reported right converts into one share of Becton Dickinson common stock on a one-for-one basis. The position therefore represents an economic interest in future shares, rather than immediate ownership of common stock, until the distribution conditions are satisfied and conversion occurs.

What adjustments affected the director’s previously reported BDX derivative securities?

The filing notes that the reported balance reflects adjustments from combining Becton Dickinson’s Biosciences and Diagnostic Solutions businesses with Waters Corp. These adjustments changed the number of derivative securities previously reported, aligning the director’s deferred rights with the restructured business arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 05:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huffines Robert Luther

(Last) (First) (Middle)

C/O BECTON, DICKINSON AND COMPANY

1 BECTON DRIVE

(Street)

FRANKLIN LAKES NEW JERSEY 07417

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Rights to Common Stock Under BD Deferred Compensation Plan	(1)	05/08/2026		A		210		(2)	(2)	Common Stock	210	$149.04	404(3)(4)	D

Explanation of Responses:

1. The securities convert to common stock on a one-for-one basis.

2. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

3. Includes rights acquired through dividend investment since the last report filed by the reporting person.

4. Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

Remarks:

	Donna Kalazdy, by power of attorney from Robert Luther Huffines	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)